title: Impotence in diabetic men.
abstract: Studies relating to pathogenetic mechanisms resulting in impotence in diabetic subjects have been reviewed. Erectile dysfunction was reported to occur in 50 to 75 percent of diabetic patients and the prevalence appeared to increase with age. Contributions of vascular, endocrine, and neurologic system alterations result in this disturbing condition, but a detailed analysis of all the parameters was not found in any individual study. In our review of 301 veterans presenting to a sexual dysfunction clinic, the clinical and hormonal alterations in the diabetic patients closely resemble those seen in nondiabetic impotent subjects. Atherosclerotic vascular changes play an important predisposing role in the development of impotence. A difference exists between the prevalences of associated medical conditions in diabetic patients taking insulin, compared with those receiving oral agents or receiving dietary management. The high prevalence of impotence in diabetic patients seems to be due to the high prevalence of its vascular complications. Considering the availability of useful therapeutic approaches, it is mandatory to evaluate all diabetic men for the presence of impotence.
authors.affiliation: Department of Medicine, Sepulveda Veterans Administration Medical Center, California 91343.
authors.forename: F E
authors.initials: FE
authors.lastname: Kaiser
authors.forename: S G
authors.initials: SG
authors.lastname: Korenman
mesh_terms: D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000378:metabolism; D003925:Diabetic Angiopathies / Q000150:complications; D003929:Diabetic Neuropathies / Q000150:complications; D007172:Erectile Dysfunction / Q000209:etiology* / Q000523:psychology / Q000628:therapy; D006728:Hormones / Q000378:metabolism; D006801:Humans; D008297:Male; D018377:Neurotransmitter Agents / Q000378:metabolism; D010410:Penile Erection
chemical_list: D006728:Hormones; D018377:Neurotransmitter Agents